{
  "metadata": {
    "source": "Finance MCP get_customer_ltv | localhost:3000",
    "generatedAt": "2026-02-10",
    "notes": "East Region accounts - 36 verified from MCP, mapped to East territories"
  },
  "top20Customers": [
    {"rank": 1, "name": "Abbott Laboratories", "ltv": 2555622, "tenure": "3 years", "avgAnnualRevenue": 1937966, "revenue2025": 1937966, "revenue2024": 617657, "gp": 47.1, "trend": "growing", "territory": "Mid-Atlantic"},
    {"rank": 2, "name": "Bausch Health", "ltv": 1300000, "tenure": "5 years", "avgAnnualRevenue": 739000, "revenue2025": 739000, "revenue2024": 505700, "gp": 29.4, "trend": "growing", "territory": "NJ Pharma"},
    {"rank": 3, "name": "Takeda Pharmaceuticals", "ltv": 1220000, "tenure": "6 years", "avgAnnualRevenue": 702000, "revenue2025": 702000, "revenue2024": 373100, "gp": 14.5, "trend": "growing", "territory": "Genetown"},
    {"rank": 4, "name": "Johnson & Johnson", "ltv": 1533747, "tenure": "8+ years", "avgAnnualRevenue": 432438, "revenue2025": 432438, "revenue2024": 500005, "gp": 32.4, "trend": "declining", "territory": "NJ Pharma"},
    {"rank": 5, "name": "Regeneron Pharmaceuticals", "ltv": 436000, "tenure": "2 years", "avgAnnualRevenue": 436000, "revenue2025": 436000, "revenue2024": 0, "gp": 63.0, "trend": "growing", "territory": "NJ Pharma"},
    {"rank": 6, "name": "Integra LifeSciences", "ltv": 1290000, "tenure": "6 years", "avgAnnualRevenue": 266000, "revenue2025": 266000, "revenue2024": 517500, "gp": 37.0, "trend": "declining", "territory": "NJ Pharma"},
    {"rank": 7, "name": "Spectranetics", "ltv": 810000, "tenure": "4 years", "avgAnnualRevenue": 242000, "revenue2025": 242000, "revenue2024": 496000, "gp": 26.4, "trend": "declining", "territory": "Mid-Atlantic"},
    {"rank": 8, "name": "Harmony Biosciences", "ltv": 400000, "tenure": "3 years", "avgAnnualRevenue": 127000, "revenue2025": 127000, "revenue2024": 123900, "gp": 81.6, "trend": "growing", "territory": "Genetown"},
    {"rank": 9, "name": "Alnylam Pharmaceuticals", "ltv": 250000, "tenure": "4 years", "avgAnnualRevenue": 110000, "revenue2025": 110000, "revenue2024": 101000, "gp": 71.5, "trend": "growing", "territory": "Genetown"},
    {"rank": 10, "name": "Ironwood Pharmaceuticals", "ltv": 200000, "tenure": "3 years", "avgAnnualRevenue": 102000, "revenue2025": 102000, "revenue2024": 52600, "gp": 79.1, "trend": "growing", "territory": "Genetown"},
    {"rank": 11, "name": "Astellas Gene Therapies", "ltv": 260000, "tenure": "3 years", "avgAnnualRevenue": 93000, "revenue2025": 93000, "revenue2024": 82800, "gp": 40.2, "trend": "growing", "territory": "Genetown"},
    {"rank": 12, "name": "Direct Biologics", "ltv": 190000, "tenure": "2 years", "avgAnnualRevenue": 83000, "revenue2025": 83000, "revenue2024": 91900, "gp": 56.3, "trend": "stable", "territory": "NJ Pharma"},
    {"rank": 13, "name": "Boehringer Ingelheim", "ltv": 130000, "tenure": "3 years", "avgAnnualRevenue": 44000, "revenue2025": 44000, "revenue2024": 0, "gp": 53.1, "trend": "growing", "territory": "NJ Pharma"},
    {"rank": 14, "name": "Moderna", "ltv": 70000, "tenure": "2 years", "avgAnnualRevenue": 37000, "revenue2025": 37000, "revenue2024": 36800, "gp": 92.8, "trend": "stable", "territory": "Genetown"},
    {"rank": 15, "name": "Intellia Therapeutics", "ltv": 130000, "tenure": "3 years", "avgAnnualRevenue": 37000, "revenue2025": 37000, "revenue2024": 37100, "gp": 96.6, "trend": "stable", "territory": "Genetown"},
    {"rank": 16, "name": "Alexion Pharmaceuticals", "ltv": 100000, "tenure": "3 years", "avgAnnualRevenue": 34000, "revenue2025": 34000, "revenue2024": 33500, "gp": 100.0, "trend": "stable", "territory": "Genetown"},
    {"rank": 17, "name": "Formation Bio", "ltv": 140000, "tenure": "2 years", "avgAnnualRevenue": 30000, "revenue2025": 30000, "revenue2024": 17200, "gp": 27.9, "trend": "growing", "territory": "Genetown"},
    {"rank": 18, "name": "Ipsen Pharma", "ltv": 100000, "tenure": "3 years", "avgAnnualRevenue": 26000, "revenue2025": 26000, "revenue2024": 0, "gp": 88.6, "trend": "growing", "territory": "Genetown"},
    {"rank": 19, "name": "Provention Bio (Sanofi)", "ltv": 100000, "tenure": "2 years", "avgAnnualRevenue": 24000, "revenue2025": 24000, "revenue2024": 30300, "gp": 86.3, "trend": "declining", "territory": "NJ Pharma"},
    {"rank": 20, "name": "Caribou Biosciences", "ltv": 40000, "tenure": "2 years", "avgAnnualRevenue": 22000, "revenue2025": 22000, "revenue2024": 13800, "gp": 72.5, "trend": "growing", "territory": "Genetown"}
  ],
  "ltvByYear": [
    {"year": 2023, "totalLtv": 7200000, "avgCustomerLtv": 300000, "totalRevenue": 2800000},
    {"year": 2024, "totalLtv": 9500000, "avgCustomerLtv": 340000, "totalRevenue": 3990000},
    {"year": 2025, "totalLtv": 12140000, "avgCustomerLtv": 337000, "totalRevenue": 5570000}
  ],
  "ltvDistribution": {
    "tier1_over5M": {"count": 0, "totalLtv": 0, "pctOfTotal": 0, "customers": []},
    "tier2_2to5M": {"count": 1, "totalLtv": 2555622, "pctOfTotal": 21.0, "customers": ["Abbott"]},
    "tier3_1to2M": {"count": 4, "totalLtv": 5343747, "pctOfTotal": 44.0, "customers": ["Bausch Health", "Takeda", "J&J", "Integra"]},
    "tier4_under1M": {"count": 31, "totalLtv": 4245318, "pctOfTotal": 35.0, "customers": ["Plus 31 other East accounts"]}
  },
  "eastSummary": {
    "totalCustomers": 36,
    "totalLTV": 12140000,
    "totalRevenue2025": 5570000,
    "totalRevenue2024": 3990000,
    "yoyGrowth": 39.5,
    "blendedGP": 43.1,
    "openPipeline": 14050000
  },
  "territoryLTV": {
    "Genetown": {"customers": 18, "ltv": 3120000, "revenue2025": 1350000, "gp": 43.1},
    "NJPharma": {"customers": 10, "ltv": 5010000, "revenue2025": 2020000, "gp": 40.7},
    "ResearchTriangle": {"customers": 0, "ltv": 0, "revenue2025": 0, "gp": 0},
    "MidAtlantic": {"customers": 8, "ltv": 4020000, "revenue2025": 2200000, "gp": 45.2}
  }
}
